AIFF Stock Summary and Trading Ideas (Firefly Neuroscience | NASDAQ:AIFF)

Firefly Neuroscience Inc is an AI company developing neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support outcomes for people suffering from mental illnesses and cognitive disorders. The Company has one reportable segment: the BNA platform. The Company derives revenue from North America.

Firefly Neuroscience trades on the NASDAQ stock market under the symbol AIFF.

As of December 19, 2025, AIFF stock price climbed to $1.34 with 59,912 million shares trading.

AIFF has a beta of 3.13, meaning it tends to be more sensitive to market movements. AIFF has a correlation of 0.14 to the broad based SPY ETF.

AIFF has a market cap of $18.07 million. This is considered a Sub-Micro Cap stock.

The top ETF exchange traded funds that AIFF belongs to (by Net Assets): VTI, VXF, IWC.

AIFF has underperformed the market in the last year with a price return of -44.2% while the SPY ETF gained +18.1%. AIFF has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -53.6% and -17.8%, respectively, while the SPY returned +2.8% and -0.5%, respectively.

AIFF support price is $1.23 and resistance is $1.35 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AIFF shares will trade within this expected range on the day.